The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...
As secretary of the HHS, Kennedy would oversee major health agencies, including the Food and Drug Administration (FDA), the ...
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
( The Hill) — A New York state doctor was indicted by a Louisiana grand jury Friday for prescribing abortion medication via ...
Cal Yee Farms' dark chocolate walnuts, dark chocolate almonds and dark chocolate apricots have been given a Class 1 recall ...
Severe food sensitivities and allergies affect millions of Americans, according to the FDA. The nine "major" food allergens ...
The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...